[Pneumocystis carinii pneumopathy in rheumatoid polyarthritis treated by methotrexate in a patient with pulmonary asbestosis].
Rolland
Y
Y
Cantagrel
A
A
Laroche
M
M
Mazières
B
B
D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D001195:Asbestosis / Q000150:complications*; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000209:etiology*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D008727:Methotrexate
Pneumopathie à Pneumocystis carinii au cours d'une polyarthrite rhumatoïde traitée par méthotrexate chez un patient souffrant d'asbestose pulmonaire.